Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regenfast for alveolar ridge preservation after tooth extraction
ACTRN12624000190505Phase 2Not yet recruiting
- Sponsor
- The University of Western Australia
- Start
- Mar 2024
- Modality
- Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label trial of Regenfast in tooth extraction (2 arms), sponsored by The University of Western Australia. Primary endpoints: Hard-tissue dimensional changes and Soft tissue thickness changes. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
Regenfast
03
Conditions
tooth extraction
Beyond the preview
Go deeper on ACTRN12624000190505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000190505.